DVA vs TFX: fair value comparison
DaVita Inc. and Teleflex Incorporated · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, DVA currently sits closer to the top of our ranking by discount to fair value.
| DVA | TFX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $179.25 | $126.11 |
| 12-month range | $103.87–$240.96 | $100.34–$142.05 |
| Rank by discount to fair value | #29 of 108 Healthcare | #102 of 108 Healthcare |
| Quality grade | C | C |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | Declining |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Undervalued | — |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: DVA fair value analysis · TFX fair value analysis